FDA Approves Mylan’s Herceptin Biosimilar

07.12.2017 - The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...